Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 100 for “"polyQ"”.
-
Model polyQ proteins based on the beta-lactamase BlaP: How non-polyQ regions influence the polyQ length-dependent aggregation process
… nine disorders are classified as polyglutamine (polyQ) diseases, for which no treatment is yet available. They are all characterized by the pathological expansion of a poly(CAG) sequence, above a specific threshold, within the coding sequence of nine unrelated genes, translated in nine polyQ …
-
Early conformational changes control spontaneous polyQ-mediated huntingtin polymerization
… Parkinson’s disease (PD) and polyglutamine (polyQ) diseases, such as Huntington’s disease (HD). Increasing experimental evidence indicates that conformational changes in disease proteins that precede aggregation are critical for pathogenesis in protein misfolding disorders. Despite the …
-
Protein Kinase CK2alpha prime: A Unifying Regulator and Therapeutic Candidate in PolyQ Expansion Disorders and Tauopathies
… disorders including polyglutamine (PolyQ) expansion disorders such as Huntington’s disease (HD) and Spinocerebellar axtaxia 3 (SCA3), as well as Parkinsons disease (PD), Alzheimer’s disease (AD), Frontotemporal dementia (FTD), and Amyotrophic lateral sclerosis (ALS). Despite this the …
-
Structure and Thermodynamics of Polyglutamine Peptides and Amyloid Fibrils via Metadynamics and Molecular Dynamics Simulations
Aggregation of polyglutamine (polyQ)-rich polypeptides in neurons is a marker for nine neurodegenerative diseases. The molecular process responsible for the formation of polyQ fibrils is not well understood and represents a growing area of study. To enable development of treatments that could …
-
Physiological and pathological role of serine 96 phosphorylation in the regulation of androgen receptor
… of a CAG tandem repeat encoding a polyglutamine (polyQ) tract in the androgen receptor (AR) gene. SBMA belongs to the family of polyQ diseases, which includes eight other neurological diseases caused by the same mutation in unrelated genes. PolyQ diseases share common features, such as that polyQ …
-
Nanobodies as tools to investigate the mechanism of aggregation of chimeric proteins made by the insertion of polyglutamine stretches into the beta-lactamase BlaP
… ten disorders, referred to as polyglutamine (polyQ) diseases and including Huntington's disease and several spinocerebellar ataxias, are associated with ten proteins within which a polyQ tract is expanded above a threshold of typically 35-45 glutamine residues. Such expanded polyQ tracts lead …
-
Structural study of polyglutamine and molecular mechanism of toll-like receptor signaling
… of a CAG repeats encoding polyglutamine (polyQ) in the first exon of Huntingtin (Htt) gene. In HD patients, polyQ contains 36-183 glutamine residues, whereas normal individuals have a polyQ of only 8-35 residues. To elucidate this threshold phenomenon of polyQ aggregation, fluorescence …
-
Creation of model proteins to investigate the mechanism of aggregation of expanded-polyglutamine proteins. Insertion of polyglutamine tracts into the ß-lactamase BlaP
Polyglutamine (polyQ) diseases are characterized by the formation of intranuclear amyloid-like aggregates by proteins containing an expansion of a polyQ tract above a threshold length. These insoluble aggregates and/or some of their soluble precursors are thought to play a role in the pathogenesis …
-
Aggregationsverhalten des Polyglutaminproteins Ataxin-3 in vitro und in Zellkultur
Neurodegenerative Polyglutamin (polyQ)-Erkrankungen sind durch neuronalen Zellverlust und die Bildung von intrazellulären Proteinablagerungen (Aggregaten) charakterisiert, deren Rolle nicht exakt geklärt ist. Es wird jedoch davon ausgegangen, daß sie die Pathogenese reflektieren und untrennbar mit …
-
The Importance Of Protein Context In Spinocerebellar Ataxia Type 3
… is a member of the family of polyglutamine (polyQ) neurodegenerative disorders that includes Huntington's Disease and several other SCAs. SCA3, the most common dominant ataxia in the world, is caused by polyQ tract expansion in the protein, ataxin-3. How SCA3 occurs and how to treat it remain …
-
Investigating Protein Aggregation in Dictyostelium discoideum Biology and Stress Response
… example being the expanded polyglutamine (polyQ) tracts present in the nine polyQ diseases, including Huntington’s disease. PolyQ aggregation has been studied in a wide array of model organisms in which proteins containing expanded polyQ will form cytotoxic aggregates. However, previous …
-
Genomic characterization of human traits associated with polyglutamine disease genes and modifiers
Background: Polyglutamine (polyQ) diseases, such as Huntington disease (HD) and certain spinocerebellar ataxia, are a group of severe neurodegenerative disorders caused by duplication of the glutamine codon. These conditions currently lack effective treatments, and most therapeutics in development …
-
Regulation of the redox homeostasis during polyglutamine misfolding in Huntington’s Disease
… cellular models of intracellular polyglutamine (polyQ) protein misfolding were established for mechanistic studies.<br/><br/>Various in vitro transient and stable cell expression systems expressing an N-terminal fragment of huntingtin (htt) (httExon 1, httEx1) with/or without a polyQ expansion …
-
DIFFERENT APPROACHES TO UNDERSTAND AND COUNTERACT SPINAL AND BULBAR MUSCOLAR ATROPHY (SBMA).
… which results in a longer polyglutamine tract (polyQ) at the N-terminus of the protein. PolyQ tract triggers AR protein misfolding and aggregation and leads to nuclear toxicity and cell death. Many efforts have been done to examine in depth disease pathogenesis and to find strategies to …
-
TATA binding protein in Alzheimer's Disease
… diseases, including the heritable polyglutamine (polyQ) disorders such as Huntington disease (HD) and the spinocerebellar ataxias (SCAs). One of this family of disorders, SCA17, is caused by an expansion of a polymorphic polyQ repeat in TATA binding protein (TBP), an essential transcription …
-
The role of polyglutamine expansion and protein context in disease-related huntingtin/lipid interactions.
… is directly caused by an expanded polyglutamine (polyQ) domain in htt, leading to a diverse population of aggregate species, such as oligomers, fibrils, and annular aggregates. Furthermore, the length of this polyQ domain is directly related to onset and severity of disease. The first 17 amino …
Page 1 of 5